본문 바로가기

Journals

  • Home
  • Cyber Information Center
  • Journals
Journals
Journal Corresponding Author Writer,Title,Journal,Publication;Year;Page:Volume(Impact Factor)
First Author
Long-Term Cancer Incidence Trends in Korea (2001-2020): An Age-Period-Cohort and Joinpoint Analysis with a Focus on Younger Cohorts Chung Jinsoo
(Immuno-oncology Branch)

Lee Hyung Ho
(Center for Prostate Cancer)
. Long-Term Cancer Incidence Trends in Korea (2001-2020): An Age-Period-Cohort and Joinpoint Analysis with a Focus on Younger Cohorts. MEDICINA-LITHUANIA. 2025-12-08; 2025; 61(12):2179~. IF 2.4 (2024)
Narciclasine as a potential therapeutic agent to overcome EGFR-TKI resistance in non-small cell lung cancer Shim Jae Gal
(Cancer Metastasis Branch)

Sung Jee Young
(Cancer Metastasis Branch)
. Narciclasine as a potential therapeutic agent to overcome EGFR-TKI resistance in non-small cell lung cancer. JOURNAL OF TRANSLATIONAL MEDICINE. 2025-12-05; 2025; 23(1):1380~. IF 7.5 (2024)
Functional profiling of the oral microbiome reveals microbial and oncogenic signatures in never-smoking female patients with oral squamous cell carcinoma Choi Sung Weon
(Rare & Pediatric Cancer Branch)

Kim Sung Min
(Branch of Oral Maxillofacial Surgery)
. Functional profiling of the oral microbiome reveals microbial and oncogenic signatures in never-smoking female patients with oral squamous cell carcinoma. JOURNAL OF ORAL MICROBIOLOGY. 2025-12-04; 2025; 17(1):2594842~. IF 5.5 (2024)
Expert consensus on the clinical use of cladribine tablets for treating relapsing multiple sclerosis in the asia-pacific region
()

Kim Ho Jin
(Immuno-oncology Branch)
. Expert consensus on the clinical use of cladribine tablets for treating relapsing multiple sclerosis in the asia-pacific region. MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2025-12-04; 2025; 105:106897~. IF 2.9 (2024)
Targeting S1PR1 in Thyroid Cancer: Functional Characterization and Proteasome-Mediated Suppression by Quercetin Ryu Jun sun
(Department of Otorhinolaryngology)


()
. Targeting S1PR1 in Thyroid Cancer: Functional Characterization and Proteasome-Mediated Suppression by Quercetin. MOLECULAR CARCINOGENESIS. 2025-12-03; 2025; :~. IF 3.2 (2024)
Evaluation of false positive and false negative errors in targeted next generation sequencing Hong Kyeong Man
(Cancer Molecular Biology Branch)

Youngbeen Moon
(Bioinformatics Analysis Team)
. Evaluation of false positive and false negative errors in targeted next generation sequencing. GENOME BIOLOGY. 2025-12-01; 2025; 26(1):409~. IF 9.4 (2024)
K-LARS trial: protocol for a multicentre randomised controlled trial evaluating a knowledge-enhanced digital intervention to prevent low anterior resection syndrome in Korea Sohn Dae Kyung
(Medical Engineering Branch)


()
. K-LARS trial: protocol for a multicentre randomised controlled trial evaluating a knowledge-enhanced digital intervention to prevent low anterior resection syndrome in Korea. BMJ OPEN. 2025-11-29; 2025; 15(11):e107819~. IF 2.3 (2024)
Development of a real-time tongue motion monitoring system for managing swallowing-induced motion in neck cancer radiation therapy Shin Dong ho
(Department of Radiation oncology)


()
. Development of a real-time tongue motion monitoring system for managing swallowing-induced motion in neck cancer radiation therapy. MEDICAL PHYSICS. 2025-11-27; 2025; 52(12):e70137~. IF 3.2 (2024)
Lorlatinib in Tyrosine Kinase Inhibitor-Naive Advanced ROS1-Positive Non-Small Cell Lung Cancer: A Phase 2 Nonrandomized Clinical Trial Han Ji-Youn
(Anticancer Resistance Branch )

Ahn Beung Chul
(Targeted Therapy Branch)
. Lorlatinib in Tyrosine Kinase Inhibitor-Naive Advanced ROS1-Positive Non-Small Cell Lung Cancer: A Phase 2 Nonrandomized Clinical Trial. JAMA ONCOLOGY. 2025-11-26; 2025; 12(1):84~89. IF 20.1 (2024)
Pattern of first recurrence in advanced epithelial ovarian, fallopian tube and peritoneal cancers treated with cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy LIM MYONG CHEOL
(Department of Obstetrics and Gynecology)

Kim Ji Hyun
(Department of Obstetrics and Gynecology)
. Pattern of first recurrence in advanced epithelial ovarian, fallopian tube and peritoneal cancers treated with cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy. JOURNAL OF GYNECOLOGIC ONCOLOGY. 2025-11-25; 2025; 37:e52~. IF 3.7 (2024)
First page Prev paging 1 2 3 4 5 6 7 8 9 10 next paging last page